Preparation of Class Y Immunoglobulins that Neutralize the Marburg Virus-Reference-Cited by-同舟云学术

Preparation of Class Y Immunoglobulins that Neutralize the Marburg Virus

Published:2021-02-07 Issue:4 Volume: Page:86-91
ISSN:2658-719X
Container-title:Problems of Particularly Dangerous Infections
language:
Short-container-title:Problemy Osobo Opasnykh Infektsii

Author:

Polezhaeva O. A.¹^ORCID,Zybkina A. V.¹,Zaikovskaya A. V.¹^ORCID,P’yankov O. V.¹,P’yankov S. A.¹,Semenova A. V.¹,Semenova G. V.¹,Shcherbakov D. N.¹^ORCID

Affiliation:

1. State Scientific Center of Virology and Biotechnology “Vector”

Abstract

The aim was to study the possibility of inducing Marburg-neutralizing chicken antibodies (MARV) using various immunogens.Materials and methods. Recombinant vaccinia virus expressing the surface glycoprotein (GP) transgene MARV of Musoke strain and pseudovirus particles exhibiting GP of three strains of MARV – Popp, Musoke and DRC2000 based on lentivirus and recombinant strain of vesicular stomatitis virus (VSV) were used as immunogens. Two groups of birds were involved in the study. Chickens were immunized 9 times: first time they were injected with the recombinant vaccinia virus, and then 8 times – with pseudovirus particles (based on lentivirus and a recombinant strain of the vesicular stomatitis virus). The accumulation of specific antibodies was evaluated by enzyme-linked immunosorbent assay (ELISA). We used recombinant VSV exhibiting GP MARV, and natural MARV strain Popp for the analysis of accumulation of neutralizing antibodies.Results and discussion. We have developed an effective immunization schedule for chickens with three recombinant constructs presenting GP MARV, which results in the induction of chicken IgY antibodies against Marburg virus with a titer in ELISA from 1:100 to 1:1 million. The obtained IgY neutralize MARV pseudoviruses (Popp, DRC2000, Musoke) at a dilution of 1/256 to 1/1024 and the natural MARV virus of the Popp strain at a dilution of 1/8. More stable results were demonstrated by immunization using Freund’s incomplete adjuvant.

Publisher

Russian Research Anti-Plague Institute Microbe

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology,Epidemiology

Reference19 articles.

1. Geisbert T.W., Hensley L.E., Kagan E., Yu E.Z., Geisbert J.B., Daddario-DiCaprio K., Fritz E.A., Jahrling P.B., McClintock K., Phelps J.R., Lee A.C.H., Judge A., Jeffs L.B., MacLachlan I. Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference. J. Infect. Dis. 2006; 193(12):1650–7. DOI: 10.1086/504267.

2. Enterlein S., Warfield K.L., Swenson D.L., Stein D.A., Smith J.L., Gamble C.S., Kroeker A.D., Iversen P.L., Bavari S., Mühlberger E. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob. Agents Chemother. 2006; 50(3):984–93. DOI: 10.1128/AAC.50.3.984- 993.2006.

3. Warfield K.L., Swenson D.L., Olinger G.G., Nichols D.K., Pratt W.D., Blouch R., Stein D.A., Aman M.J., Iversen P.L., Bavari S. Gene-specific countermeasures against Ebola virus based on anti- sense phosphorodiamidate morpholino oligomers. PLoS Pathog. 2006; 2(1):e1. DOI: 10.1371/journal.ppat.0020001.

4. Sokolova A.S., Baranova D.V., Yarovaya O.I., Baev D.S., Tolstikova T.G., Salakhutdinov N.F., Polezhaeva O.A., Zybkina A.V., Shcherbakov D.N. Synthesis of (1S)-(+)-camphor-10-sulfonic acid derivatives and investigations in vitro and in silico of their an- tiviral activity as the inhibitors of filovirus infections. Russ. Chem. Bull. 2019; 68(5):1041–6. DOI: 10.1007/s11172-019-2517-0.

5. Flyak A.I., Ilinykh P.A., Murin C.D., Garron T., Shen X., Fusco M.L., Hashiguchi T., Bornholdt Z.A., Slaughter J.C., Sapparapu G., Klages C., Ksiazek T.G., Ward A.B., Saphire E.O., Bukreyev A., Crowe J.E. Jr. Mechanism of human antibody-mediated neutraliza- tion of Marburg virus. Cell. 2015; 160(5):893–903. DOI: 10.1016/j.cell.2015.01.031.